Bioinformatic Analysis of the Expression and Clinical Significance of the DNA Replication Regulator MCM Complex in Bladder Cancer
Ru Chen,Bing Hu,Ming Jiang,Wen Deng,Ping Zheng,Bin Fu
DOI: https://doi.org/10.2147/IJGM.S368573
IF: 2.145
2022-06-07
International Journal of General Medicine
Abstract:Ru Chen, 1, 2, &ast Bing Hu, 1, &ast Ming Jiang, 1, &ast Wen Deng, 1 Ping Zheng, 3 Bin Fu 1, 4 1 Department of Urology, the First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, People's Republic of China; 2 Department of Urology, The First Hospital of Putian City, Putian, Fujian, People's Republic of China; 3 Department of Urology, Shangrao municipal Hospital, Shangrao, 334000, Jiangxi Province, People's Republic of China; 4 Jiangxi Institute of Urology, Nanchang City, Jiangxi Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bin Fu, Email Objective: The minichromosome maintenance (MCM) complex (MCM2, MCM3, MCM4, MCM5, MCM6, and MCM7), which regulates DNA replication and cell cycle progression, is essential for the development and progression of multiple tumors, but their role in bladder cancer development remains unclear. In the present study, the biological role and clinical significance of the MCM complex in bladder cancer were systematically elucidated. Materials and Methods: We analyzed DNA mutations, mRNA expression and protein levels, protein–protein interaction (PPI) networks, functional enrichment, prognostic value of MCM2/3/4/5/6/7 in bladder urothelial carcinoma (BLC) and the connections between the immune cell infiltration and the overall survival of BLC patients with the MCM expression levels using Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), the Cancer Genome Atlas database (TCGA), Human Protein Atlas, UALCAN, STRING, cBioPortal, TIMER and GSCALite databases. Results: The outcomes showed that the mRNA expression level of each member of the MCM complex was significantly correlated with histologic grade and tumor histology in BLC patients. Moreover, survival analysis showed that MCM/2/3/4/5/6/7 mRNA expressions were significantly associated with prognosis in patients with bladder cancer. Moreover, we experimentally validated the overexpression of the MCM2-7 complex in the BLC. Based on functional enrichment and PPI network analysis, the MCM complex might promote the progression of bladder cancer by activating DNA replication and accelerating cell cycle progression. In addition, MCM2/3/4/5/6/7 genes were also significantly associated with tumor immune cells infiltration and the drug sensitivity in BLC. Conclusion: Our study suggests that the MCM complex especially MCM2/4/6/7 might be potential molecular therapeutic targets for BLC treatment and might be useful biomarkers for diagnosis and prognosis. Keywords: bladder cancer, minichromosome maintenance complex, bioinformatics, potential biomarkers Bladder cancer (BC), a common urothelial carcinoma, is characterized by high morbidity and mortality. 1 BLC is more than four times more common in men than in women, with a worldwide incidence of 9.6 per 100,000 and 2.4 per 100,000. In men, BLC ranks the sixth of all newly diagnosed cancers and the ninth most deadly tumor worldwide. 2 Bladder cancer is divided into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Lots of patients' futures developed into muscular invasion urothelial carcinomas with a very lower 5-year survival rate. Due to the high incidence and recurrence rates, it is necessary to investigate the relevant genetic pathways underlying the genesis and development of bladder cancer to look for a therapeutic target to improve the survival rates of patients with bladder cancer. Genome instability is defined as the high frequency of mutations within the genome of a cellular lineage. Genomic variation, which helps regulate cancer genes, includes single-nucleotide variants, small insertions and deletions (indels), and copy number variants. 3 Dysregulation of DNA replication in cells contributes to tumor formation and progression. Minichromosome maintenance proteins (MCMs) were originally identified in Saccharomyces cerevisiae as necessary factors for the maintenance of extrasomal DNA. 4 It has been reported that MCMs are essential for tightly regulating DNA replication to maintain normal cellular processes, especially during DNA initiation as well as elongation. In many studies, genomic instability caused by MCM variants has been shown to be associated with cancer prognosis. Abnormal expression and activation of MCMs are often detected in various precancerous lesions and malignancies and contribute to genomic instability and uncontrolled cell cycle progression. The MCM2-7 complex proteins in the MCM family are related to each other and form a family of DNA hel -Abstract Truncated-
medicine, general & internal